Nathalie Dubois-Stringfellow

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Scott Willoughby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathalie Dubois-Stringfellow:

Company Role Class Num Shares Value Price $ Report Date Ownership
SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Common Stock 332,769 $85,787 $0.2578 21 Apr 2026 Direct
SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Stock Option (Right to Buy) 800,000 01 Apr 2026 Direct

Insider Reports Filed by Nathalie Dubois-Stringfellow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGMO SANGAMO THERAPEUTICS, INC 21 Apr 2026 1 -$89,184 4 SVP-CHIEF DEVELOPMENT OFFICER 23 Apr 2026, 16:05
SGMO SANGAMO THERAPEUTICS, INC 01 Apr 2026 1 $0 4 SVP-CHIEF DEVELOPMENT OFFICER 03 Apr 2026, 16:15
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2026 2 -$6,781 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Feb 2026, 21:40
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2026 1 -$14,615 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Jan 2026, 16:06
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2025 1 -$1,060 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Nov 2025, 16:06
SGMO SANGAMO THERAPEUTICS, INC 22 Oct 2025 1 -$28,869 4 SVP-CHIEF DEVELOPMENT OFFICER 24 Oct 2025, 17:00
SGMO SANGAMO THERAPEUTICS, INC 24 Aug 2025 1 -$1,051 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Aug 2025, 19:59
SGMO SANGAMO THERAPEUTICS, INC 22 Jul 2025 1 -$15,289 4 SVP-CHIEF DEVELOPMENT OFFICER 24 Jul 2025, 16:56
SGMO SANGAMO THERAPEUTICS, INC 24 May 2025 1 -$848 4 SVP-CHIEF DEVELOPMENT OFFICER 28 May 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 22 Apr 2025 1 -$24,738 4 SVP-CHIEF DEVELOPMENT OFFICER 24 Apr 2025, 16:07
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2025 4 -$3,239 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Feb 2025, 17:32
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2025 1 -$149,032 4 SVP-CHIEF DEVELOPMENT OFFICER 24 Jan 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2024 2 -$6,285 4 SVP-CHIEF DEVELOPMENT OFFICER 26 Nov 2024, 16:08
SGMO SANGAMO THERAPEUTICS, INC 24 Aug 2024 2 -$2,834 4 SVP-CHIEF DEVELOPMENT OFFICER 27 Aug 2024, 16:37
SGMO SANGAMO THERAPEUTICS, INC 24 May 2024 2 -$1,977 4 SVP-CHIEF DEVELOPMENT OFFICER 29 May 2024, 17:18
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2024 2 -$11,847 4 SVP-CHIEF DEVELOPMENT OFFICER 27 Feb 2024, 17:13
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2024 1 $0 4 SVP-CHIEF DEVELOPMENT OFFICER 24 Jan 2024, 16:40
SGMO SANGAMO THERAPEUTICS, INC 25 Nov 2023 1 -$559 4 SVP-Chief Development Officer 28 Nov 2023, 16:16
SGMO SANGAMO THERAPEUTICS, INC 25 Aug 2023 1 -$1,126 4 SVP-Chief Development Officer 29 Aug 2023, 16:13
SGMO SANGAMO THERAPEUTICS, INC 25 May 2023 1 -$1,944 4 SVP-Chief Development Officer 30 May 2023, 16:43
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2023 3 -$26,158 4 SVP-Chief Development Officer 06 Mar 2023, 16:08
SGMO SANGAMO THERAPEUTICS, INC 09 Sep 2022 0 $0 3 SVP-Chief Development Officer 19 Sep 2022, 19:24
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .